SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-023401
Filing Date
2022-01-31
Accepted
2022-01-31 16:29:38
Documents
14
Period of Report
2022-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d275986d8k.htm   iXBRL 8-K 30053
2 EX-10.1 d275986dex101.htm EX-10.1 62158
  Complete submission text file 0001193125-22-023401.txt   260766

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20220131.xsd EX-101.SCH 4122
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20220131_def.xml EX-101.DEF 13263
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20220131_lab.xml EX-101.LAB 21904
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20220131_pre.xml EX-101.PRE 14160
8 EXTRACTED XBRL INSTANCE DOCUMENT d275986d8k_htm.xml XML 5240
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 22574369
SIC: 2836 Biological Products, (No Diagnostic Substances)